
Brazil rejects the Russian Gamaleya Vaccine – “still has replication-competent adenovirus in it”
Brazil have turned down the Russian Gamaleya Sputnik V vaccine. There are questions raised about the manufacturing and scale-up processes. Anvisa, the Brazilian drug agency, also said that every single lot of the AD5 Gamaleya Sputnik V shot that they have data on appears to still have replication-competent adenovirus in it.
Brazil Government slides outlining the decision (PDF)
** This post was originally published on April 28, 2021 **